Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Assessment of ovarian function in adolescents and young adults after childhood cancer treatment-How accurate are young adult/parent proxy-reported outcomes?

George SA, Williamson Lewis R, McKenzie L, Cherven B, Patterson BC, Effinger KE, Mertens AC, Meacham LR.

Pediatr Blood Cancer. 2019 Sep 10:e27981. doi: 10.1002/pbc.27981. [Epub ahead of print]

PMID:
31502374
2.

Premature Ovarian Insufficiency in Childhood Cancer Survivors: A Report From the St. Jude Lifetime Cohort.

Chemaitilly W, Li Z, Krasin MJ, Brooke RJ, Wilson CL, Green DM, Klosky JL, Barnes N, Clark KL, Farr JB, Fernandez-Pineda I, Bishop MW, Metzger M, Pui CH, Kaste SC, Ness KK, Srivastava DK, Robison LL, Hudson MM, Yasui Y, Sklar CA.

J Clin Endocrinol Metab. 2017 Jul 1;102(7):2242-2250. doi: 10.1210/jc.2016-3723.

3.

Early Detection of Ovarian Dysfunction by Anti-Mullerian Hormone in Adolescent and Young Adult-Aged Survivors of Childhood Cancer.

George SA, Williamson Lewis R, Schirmer DA, Effinger KE, Spencer JB, Mertens AC, Meacham LR.

J Adolesc Young Adult Oncol. 2019 Feb;8(1):18-25. doi: 10.1089/jayao.2018.0080. Epub 2018 Oct 3.

PMID:
30281375
4.

Evidence to incorporate inclusive reproductive health measures in guidelines for childhood and adolescent cancer survivors.

Salih SM, Elsarrag SZ, Prange E, Contreras K, Osman RG, Eikoff JC, Puccetti D.

J Pediatr Adolesc Gynecol. 2015 Apr;28(2):95-101. doi: 10.1016/j.jpag.2014.05.012. Epub 2014 Jun 7.

5.

Low Anti-Müllerian Hormone in Pediatric Cancer Survivors in the Early Years after Gonadotoxic Therapy.

Elchuri SV, Patterson BC, Brown M, Bedient C, Record E, Wasilewski-Masker K, Mertens AC, Meacham LR.

J Pediatr Adolesc Gynecol. 2016 Aug;29(4):393-9. doi: 10.1016/j.jpag.2016.02.009. Epub 2016 Feb 26.

PMID:
26924632
6.

Premature ovarian insufficiency and early depletion of the ovarian reserve in the monogenic Mulibrey nanism disorder.

Karlberg S, Tiitinen A, Alfthan H, Lipsanen-Nyman M.

Hum Reprod. 2018 Jul 1;33(7):1254-1261. doi: 10.1093/humrep/dey103.

PMID:
29860321
7.

Anti-müllerian hormone compared with other ovarian markers after childhood cancer treatment.

Nyström A, Mörse H, Nordlöf H, Wiebe K, Artman M, Øra I, Giwercman A, Henic E, Elfving M.

Acta Oncol. 2019 Feb;58(2):218-224. doi: 10.1080/0284186X.2018.1529423. Epub 2018 Dec 18.

PMID:
30558460
8.

Pubertal development and primary ovarian insufficiency in female survivors of embryonal brain tumors following risk-adapted craniospinal irradiation and adjuvant chemotherapy.

DeWire M, Green DM, Sklar CA, Merchant TE, Wallace D, Lin T, Vern-Gross T, Kun LE, Krasin MJ, Boyett JM, Wright KD, Wetmore C, Broniscer A, Gajjar A.

Pediatr Blood Cancer. 2015 Feb;62(2):329-334. doi: 10.1002/pbc.25274. Epub 2014 Oct 18.

9.

Management of Primary Ovarian Insufficiency Symptoms in Survivors of Childhood and Adolescent Cancer.

Gargus E, Deans R, Anazodo A, Woodruff TK.

J Natl Compr Canc Netw. 2018 Sep;16(9):1137-1149. doi: 10.6004/jnccn.2018.7023. Review.

10.

HRT for women with premature ovarian insufficiency: a comprehensive review.

Webber L, Anderson RA, Davies M, Janse F, Vermeulen N.

Hum Reprod Open. 2017 Jul 12;2017(2):hox007. doi: 10.1093/hropen/hox007. eCollection 2017. Review.

11.

Measuring ovarian function in young cancer survivors.

Su HI.

Minerva Endocrinol. 2010 Dec;35(4):259-70. Review.

PMID:
21178920
12.

Elevated LH levels draw a stronger distinction than AMH in premature ovarian insufficiency.

Sahmay S, Usta TA, Erel T, Atakul N, Aydogan B.

Climacteric. 2014 Apr;17(2):197-203. doi: 10.3109/13697137.2013.870149. Epub 2014 Feb 4.

PMID:
24299186
13.

Impact of ovarian transposition before pelvic irradiation on ovarian function among long-term survivors of childhood Hodgkin lymphoma: A report from the St. Jude Lifetime Cohort Study.

Fernandez-Pineda I, Davidoff AM, Lu L, Rao BN, Wilson CL, Srivastava DK, Klosky JL, Metzger ML, Krasin MJ, Ness KK, Pui CH, Robison LL, Hudson MM, Sklar CA, Green DM, Chemaitilly W.

Pediatr Blood Cancer. 2018 Sep;65(9):e27232. doi: 10.1002/pbc.27232. Epub 2018 May 11.

14.

The effect of 12-month dehydroepiandrosterone supplementation on the menstrual pattern, ovarian reserve markers, and safety profile in women with premature ovarian insufficiency.

Wong QHY, Yeung TWY, Yung SSF, Ko JKY, Li HWR, Ng EHY.

J Assist Reprod Genet. 2018 May;35(5):857-862. doi: 10.1007/s10815-018-1152-2. Epub 2018 Mar 9.

15.

Physical and social characteristics and support needs of adult female childhood cancer survivors who underwent hormone replacement therapy.

Tomioka A, Maru M, Kashimada K, Sakakibara H.

Int J Clin Oncol. 2017 Aug;22(4):786-792. doi: 10.1007/s10147-017-1120-3. Epub 2017 Mar 31.

PMID:
28364312
16.

Genes involved in the pathogenesis of premature ovarian insufficiency.

Orlandini C, Regini C, Vellucci FL, Petraglia F, Luisi S.

Minerva Ginecol. 2015 Oct;67(5):421-30. Epub 2015 Jun 26. Review.

PMID:
26112693
17.
18.

Rationale and design of a cohort study on primary ovarian insufficiency in female survivors of Hodgkin's lymphoma: influence on long-term adverse effects (SOPHIA).

Krul IM, Opstal-van Winden AWJ, Zijlstra JM, Appelman Y, Schagen SB, Meijboom LJ, Serné E, Lambalk CB, Lips P, van Dulmen-den Broeder E, Hauptmann M, Daniëls LA, Aleman BMP, van Leeuwen FE.

BMJ Open. 2018 Sep 11;8(9):e018120. doi: 10.1136/bmjopen-2017-018120.

19.

Ovarian reserve after treatment with alkylating agents during childhood.

Thomas-Teinturier C, Allodji RS, Svetlova E, Frey MA, Oberlin O, Millischer AE, Epelboin S, Decanter C, Pacquement H, Tabone MD, Sudour-Bonnange H, Baruchel A, Lahlou N, De Vathaire F.

Hum Reprod. 2015 Jun;30(6):1437-46. doi: 10.1093/humrep/dev060. Epub 2015 Mar 23.

PMID:
25801499
20.

In Vitro Activation of Follicles and Fresh Tissue Auto-transplantation in Primary Ovarian Insufficiency Patients.

Zhai J, Yao G, Dong F, Bu Z, Cheng Y, Sato Y, Hu L, Zhang Y, Wang J, Dai S, Li J, Sun J, Hsueh AJ, Kawamura K, Sun Y.

J Clin Endocrinol Metab. 2016 Nov;101(11):4405-4412. Epub 2016 Aug 29.

Supplemental Content

Support Center